Description: Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement instruments, nutritional products, vehicle headlight testers, synthetic resin molded products, paper products, and insecticide and toiletry products. In addition, the company offers IT solution services; adhesive tapes; flaky titanate and compounds; IV solutions; infusion and clinical nutrition products; hydrazine; plant-based food products; reinsurance underwriting services; wine; stable isotopes; food supplements; urinary tract health products; software and services for management of mental healthcare systems; anticancer drugs; terracess; bio-pesticides; dietetic food products; spring and mineral water; and polyolefin foams. Further, it engages in the warehousing and transport, medical device operational management, shared service, environmental health management, and venture capital and incubation businesses; rental of medical devices and related products; purchase and sale of agricultural products; import and export trading business; tuberculosis research and development activities; manufacturing and development of xenotransplantation products; and processing and marketing of functional films, as well as planning, design, production, and construction of ceramic boards and arts, ceramic walls, reliefs, terracotta, ceramic OT and portraits, and ceramic sign boards; and operation of travel agency, and Hotel Ridge and California Table. Otsuka Holdings Co., Ltd. was founded in 1921 and is headquartered in Tokyo, Japan.
Home Page: www.otsuka.com
2-9 Kanda-Tsukasamachi
Tokyo,
101-0048
Japan
Phone:
81 3 6717 1410
Officers
| Name | Title |
|---|---|
| Mr. Tatsuo Higuchi | CEO, President & Representative Director |
| Mr. Makoto Inoue | COO & Representative Director |
| Mr. Yoshiro Matsuo | Executive Deputy President & Executive Director |
| Mr. Masayuki Kobayashi | Executive Director |
| Ms. Yuko Makino | CFO & Executive Director |
| Tomohiro Emura Ph.D. | Vice President of Investor Relations, Public Relations & Sustainability Promotion |
| Akiko Ryu | Senior VP & Director of Human Resource Planning Department |
| Ms. Noriko Tojo | Executive Director |
| Mr. Shuichi Takagi | Executive Director |
| Chiaki Sakurai | Senior Vice President of Nutraceutical Business, Global Strategy & Planning Headquarters |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 13.6799 |
|---|---|
| Trailing PE: | 31.8182 |
| Price-to-Book MRQ: | 1.8295 |
| Price-to-Sales TTM: | 0.0136 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 34388 |